Manfred Jung
Manfred Jung
Institute of Pharmaceutical Sciences, University of Freiburg; former University of Münster, Ottawa
Verified email at pharmazie.uni-freiburg.de - Homepage
Title
Cited by
Cited by
Year
Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
JM Wagner, B Hackanson, M Lübbert, M Jung
Clinical epigenetics 1 (3-4), 117-136, 2010
4162010
SIRT1 regulates HIV transcription via Tat deacetylation
S Pagans, A Pedal, BJ North, K Kaehlcke, BL Marshall, A Dorr, ...
PLoS biology 3 (2), e41, 2005
3612005
Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy
L Morera, M Lübbert, M Jung
Clinical epigenetics 8 (1), 1-16, 2016
2782016
Inhibitors of histone deacetylase as new anticancer agents
M Jung
Current medicinal chemistry 8 (12), 1505-1511, 2001
2712001
Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation
M Jung, G Brosch, D Kölle, H Scherf, C Gerhäuser, P Loidl
Journal of medicinal chemistry 42 (22), 4669-4679, 1999
2401999
Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins)
J Trapp, R Meier, D Hongwiset, MU Kassack, W Sippl, M Jung
ChemMedChem 2 (10), 1419-1431, 2007
2032007
The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors
A Spannhoff, AT Hauser, R Heinke, W Sippl, M Jung
ChemMedChem: Chemistry Enabling Drug Discovery 4 (10), 1568-1582, 2009
1802009
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition
J Trapp, A Jochum, R Meier, L Saunders, B Marshall, C Kunick, E Verdin, ...
Journal of medicinal chemistry 49 (25), 7307-7316, 2006
1792006
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
T Rumpf, M Schiedel, B Karaman, C Roessler, BJ North, A Lehotzky, ...
Nature communications 6 (1), 1-13, 2015
1782015
Structure–activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode
RC Neugebauer, U Uchiechowska, R Meier, H Hruby, V Valkov, E Verdin, ...
Journal of medicinal chemistry 51 (5), 1203-1213, 2008
1762008
HDAC8: a multifaceted target for therapeutic interventions
A Chakrabarti, I Oehme, O Witt, G Oliveira, W Sippl, C Romier, RJ Pierce, ...
Trends in pharmacological sciences 36 (7), 481-492, 2015
1602015
Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors
Y Zhang, M Jung, A Dritschilo, M Jung
Radiation research 161 (6), 667-674, 2004
1582004
Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates
SW Remiszewski, LC Sambucetti, P Atadja, KW Bair, WD Cornell, ...
Journal of medicinal chemistry 45 (4), 753-757, 2002
1572002
Target-based approach to inhibitors of histone arginine methyltransferases
A Spannhoff, R Heinke, I Bauer, P Trojer, E Metzger, R Gust, R Schüle, ...
Journal of medicinal chemistry 50 (10), 2319-2325, 2007
1512007
Chemically induced degradation of sirtuin 2 (Sirt2) by a proteolysis targeting chimera (PROTAC) based on sirtuin rearranging ligands (SirReals)
M Schiedel, D Herp, S Hammelmann, S Swyter, A Lehotzky, D Robaa, ...
Journal of medicinal chemistry 61 (2), 482-491, 2018
1462018
Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni
M Marek, S Kannan, AT Hauser, M Moraes Mourão, S Caby, V Cura, ...
PLoS pathogens 9 (9), e1003645, 2013
1452013
Subtype selective substrates for histone deacetylases
B Heltweg, F Dequiedt, BL Marshall, C Brauch, M Yoshida, N Nishino, ...
Journal of medicinal chemistry 47 (21), 5235-5243, 2004
1392004
Characterization of novel inhibitors of histone acetyltransferases
ED Eliseeva, V Valkov, M Jung, MO Jung
Molecular cancer therapeutics 6 (9), 2391-2398, 2007
1342007
In vitro assays for the determination of histone deacetylase activity
B Heltweg, J Trapp, M Jung
Methods 36 (4), 332-337, 2005
1302005
Impairment of prostate cancer cell growth by a selective and reversible LSD1 inhibitor
D Willmann, S Lim, S Wetzel, E Metzger, A Jandausch, W Wilk, M Jung, ...
International Journal of Cancer 128, 574-586, 2012
128*2012
The system can't perform the operation now. Try again later.
Articles 1–20